Hereditary hemochromatosis affects ~1 in 200 people of Northern European descent. Yet 𝘏𝘍𝘌 research testing remains underutilized...
More
Visit us at booth #529
In the rapidly advancing fields of pharmacogenomics (PGx) and oncology research, laboratories need scalable, reliable tools for variant detection and molecular profiling. The MassARRAY® System from Agena Bioscience delivers targeted, high-throughput genomic analysis to streamline workflows and generate high-quality, reproducible data.
Join us at AMP 2025 to explore how the Agena Bioscience MassARRAY® System and new panels—the VeriDose® Core v2.0 Panel and VeriDose® DPYD Plus Panel—enable comprehensive, guideline-aligned, and rapid analysis across key pharmacogenomic and oncology research applications.
Visit booth #529 and attend our corporate workshops on Wednesday, November 12th, 2025 to hear from leading experts as they discuss the latest advancements in PGx and oncology research.
One System, Endless Testing Possibilities
Simplify data analysis by analyzing only specific mutations, unlike other extensive approaches such as whole-genome sequencing. No bioinformatics team needed!
Target up to 50 DNA variants in a single PCR reaction and process up to 96 or 384 reactions on a single SpectroCHIP® Array, and test hundreds of mutations in a single workflow.
Detect SNPs, insertions, deletions, translocations, copy number variations, and methylation markers with one system.
Sample to results in a single day. Run up to eight 96-well or six 384-well plates in a full workday with the flexibility to process two more plates overnight.
Multiplexed analysis plus the elimination of fluorescent markers allows for the lowest price per sample.
